Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Articles published in International Journal of Drug Development and Research have been cited by esteemed scholars and scientists all around the world. International Journal of Drug Development and Research has got h-index 51, which means every article in International Journal of Drug Development and Research has got 51 average citations.

Following are the list of articles that have cited the articles published in International Journal of Drug Development and Research.

  2022 2021 2020 2019 2018

Total published articles

42 54 13 16 19

Conference proceedings

0 19 19 23 100

Citations received as per Google Scholar, other indexing platforms and portals

1275 1327 1369 1223 1250
Journal total citations count 12061
Journal impact factor 26.99
Journal 5 years impact factor 39.13
Journal cite score 46.50
Journal h-index 51
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
 Traditional and modern use of indian madder (Rubia cordifolia L.): an overview
Development and in vitro evaluation of floating multiparticulate system of repaglinide
Dietary plants for the prevention and management of kidney stones: preclinical and clinical evidence and molecular mechanisms
PREPARATION AND CHARACTERIZATION OF ZnO NANOPARTICLES USING MORINGA OLEIFERA EXTRACT BY GREEN SYNTHESIS METHOD
Mikro ve Nanoemülsiyonlar?n Farmasötik Yönden De?erlendirilmesi
Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools
Celastrol Nanoemulgel Formulation And In Vitro Penetration Test
Seasonal variation’s effect on antidiabetic activity of silver nanoparticles
Enhancement of Solubility and Bioavailability of Etravirine Solid Dispersions by Solvent Evaporation Technique with Novel Carriers
Thermal, infrared characterization and in vitro evaluation of Repaglinide solid dispersion
Studies of the Chemical Constitue (Apocynaceae) and Screen
Thermoanalytical measurements conducted on repaglinide to estimate the kinetic triplet followed by compatibility studies between the antidiabetic agent and various excipients
Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats
Formulation and evaluation of repaglinide buccal tablet: ex vivo bioadhesion study and ex vivo permeability study
Design and evaluation of self-nanoemulsifying pellets of repaglinide
Food Potential and Antioxidant Property of Cassia auriculata Seed: A Nutritionally Unexploited Legume
Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies
Nanoemulsions for Drug Delivery
Simultaneous Determination of Anthraquinone, Flavonoids, and Phenolic Antidiabetic Compounds from Cassia auriculata Seeds by Validated UHPLC Based MS/MS …
Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-?-cyclodextrin